Beneficial effect of prostaglandin E1 on hepatic allograft rejection following orthotopic liver transplantation

Transplant Proc. 1993 Oct;25(5):2890-1.

Authors

S Tancharoen¹, R M Jones, P W Angus, K J Hardy

Affiliation

¹ Victorian Liver Transplant Unit, Austin Hospital, Heidelberg, Australia.

PMID: 8212276

No abstract available

MeSH terms

Acute Disease
Alprostadil / administration & dosage
Alprostadil / pharmacology*
Graft Rejection / etiology
Graft Rejection / prevention & control*
Humans
Immunosuppressive Agents / administration & dosage
Infusions, Intravenous
Liver Transplantation / adverse effects*
Liver Transplantation / immunology
Methylprednisolone / administration & dosage
Muromonab-CD3 / administration & dosage

Substances

Immunosuppressive Agents
Muromonab-CD3
Alprostadil
Methylprednisolone